seed
Stage
About
Granular Therapeutics Limited develops novel antibody therapeutics that selectively target mast cells for disease-modifying immune modulation in chronic inflammatory diseases.
Explore Granular Therapeutics Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.